Suppliers / Compounds & building blocks
ACM Biolabs
Singapore, Singapore · acmbiolabs.com
ACM Biolabs is a clinical-stage biotechnology company developing a proprietary polymer/lipid hybrid, non-viral nanoparticle delivery platform for medicines and vaccines. It is headquartered in Singapore, with wholly-owned subsidiaries in Basel, Switzerland, and Sydney, Australia.
They take quote requests by email.
What they offer
mRNA delivery platform development
Develops the ACM Tunable Platform (ATP), a thermostable mRNA delivery vehicle designed to improve storage and delivery of mRNA vaccines.
Oligonucleotide delivery
Uses its delivery platform to deliver oligonucleotide payloads, including CpG oligonucleotides.
Small molecule delivery
Uses its delivery platform to deliver small molecule payloads.
Protein delivery
Uses its delivery platform to deliver protein payloads.
Vaccine delivery technology development
Develops delivery technology for disease prevention vaccines, including a CEPI-funded mRNA rabies vaccine program.
What they work on
- Services
- Small molecule, Antibody, Oligonucleotide, Vaccine, LNP / formulation
- Capacity
- wholly-owned subsidiaries in Basel, Switzerland, and Sydney, Australia
- Sites
- Singapore, Singapore · Basel, Switzerland · Sydney, Australia
- Serves
- global
- Address
- 71 Nanyang Drive, #02M-02 NTU Innovation Centre, Singapore 638075
- Founded
- 2011
Similar suppliers. Anthem, Aurigene Pharmaceutical Services, AxisPharm, Bio Synthesis
Found in a contract services directory. Listing built from acmbiolabs.com. Work here? Claim this listing.